x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

56:54

Delhi boy, done good

Molecule to Market: Inside the outsourcing space ·

2024/11/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Akshay Peer, co-founder and Senior Vice President of Products at TrakCel.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Akshay, covering: How the development of a patent led him into the CGT space—years before it was a market The founding story of TrakCel and getting GSK as an anchor client to support early iterations of its custom

en

55:20

Meet the Top Gun CDMO Maverick

Molecule to Market: Inside the outsourcing space ·

2024/11/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Fowler, President & CEO at Pii (Pharmaceutics International, Inc.)Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with John, covering: How a competitive family environment and navigating flight school in the Navy equipped him for a successful career Why a CDMO business is like managing chaos... under strict regulations The silver

en

58:28

Pfizer's retired manufacturing veteran

Molecule to Market: Inside the outsourcing space ·

2024/11/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Stevenson, Independent Director and Pharma industry veteran. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: Bringing an outsourcing model from UpjohnPharmacia into Pfizer and then driving manufacturing out of Pfizer into CDMOs without compromising on quality or IP Behind the scenes of Pfizer's mammoth acquisitions

en

19:26

Tasty Topics: Navigating Novo Nordisk’s Acquisition...

Molecule to Market: Inside the outsourcing space ·

2024/10/25

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Dirk Lange, CEO at Pyramid Labs Brett Alderson, President & Site Leader at NovaCina John Cameron, Director, Global Injectables Platform at Corden Pharma Janet Hoogstraate, CEO at NorthX Biologics Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, Brett, John & Janet, focusing on: Maximizing GLP-1 manufacturing capacity:

en

57:59

Reimagining drug development

Molecule to Market: Inside the outsourcing space ·

2024/10/18

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jen Nwankwo, Founder and CEO at 1910 Genetics.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jen, covering: Being the first PHD at Bain's Global HQ, and what she learned from the experience How she stumbled across AI and open innovation as it applied to R&D productivity, and accelerating clinical trials The founding story of 1910,

en

50:50

A lifetime of drug hunting

Molecule to Market: Inside the outsourcing space ·

2024/10/11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Karen Lackey, CEO at X-Chem.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Karen, covering: Why diversity of thought is essential in solving problems that have never been solved before Why did she leave the big pharma world after 30 years to join the world of academia? And how joining a global CRO enabled Karen to democratize its tech

en

58:22

The pink-haired CEO

Molecule to Market: Inside the outsourcing space ·

2024/10/04

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Emma Banks, CEO at ramarketing. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Emma Banks, CEO at ramarketing, covering: How a conversation with her late father led Emma to look out for herself and jump into the unknown The contrast of two different CEO roles - stepping from a hand-to-mouth cash-strapped tech business into a rapid-growth

en

49:55

The Harvard spin-out disrupting drug discovery

Molecule to Market: Inside the outsourcing space ·

2024/09/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Rani Powers, Founder & CEO at Pluto Bio.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Rani, covering: Her passion for coding and what drew her into the world of biology How the frustration of using clunky software in the lab led to the exploration of a better alternative... and eventually her own start-up The value of continuous

en

45:35

The rare disease champion

Molecule to Market: Inside the outsourcing space ·

2024/09/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tamar Thompson, Head of Global Corporate Affairs at Alexion, AstraZeneca Rare Disease.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology space with Tamar, covering: The epidemiological challenge of rare diseases and representing the topic at the White House Why is rare disease drug development so hard, but why is there so much interest in the area given the

en

58:18

The VC Biotech investor

Molecule to Market: Inside the outsourcing space ·

2024/09/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: How he utilized his pharma experience to become a CEO and revitalize a biotech company, positioning it for a $15bn market cap Why the biotech space had such a market downturn, and how the

en

44:57

The diamond in the rough

Molecule to Market: Inside the outsourcing space ·

2024/09/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kent Payne, CEO at Aliri Bioanalysis.Your host Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kent, covering: Being exposed to scientific efficiencies early on in his career as a bench scientist, and what it took to bring a successful NDA to market The formative years of Catalent, and helping to establish its early biologics and bioanalysis

en

01:02:29

One-hour special - The President of the PBOA

Molecule to Market: Inside the outsourcing space ·

2024/08/30

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA).Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering: The evolution of the PBOA over the last decade, the impact of M&A on the Association, and building a safe place where CDMOs belong How the industry has evolved over the last few years after

en

56:02

The puzzle-solving CEO

Molecule to Market: Inside the outsourcing space ·

2024/08/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steven Chevillotte, Chief Executive Officer at SaniSure.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steven, covering: Building a great partner through professionalization and integration while retaining founder DNA of entrepreneurship and innovation The transformation of quality components and complex assemblies to game changing

en

22:53

Summer sentiment: A life science industry check-in &...

Molecule to Market: Inside the outsourcing space ·

2024/08/16

In this mid year episode special, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the trends happening across the life sciences and outsourcing space in 2024. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain covering: The anticipated recovery of the biotech sector and where it stands now Geopolitical influences on the life sciences industry, with a focus on the CDMO sector

en

51:47

Pivoting to partnership success in clinical trial

Molecule to Market: Inside the outsourcing space ·

2024/08/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Yussuf Goolam, Co-Founder, President and CEO at RxSource.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Yussuf, covering: His family's journey from Mozambique to North America and the value of having an entrepreneurial ethos Lifelong business lessons from a window cleaning job... and the impact of going on a learning rampage The

en

01:00:24

A Sterling, CDMO leader

Molecule to Market: Inside the outsourcing space ·

2024/08/02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Cook, CEO at Sterling Pharma Solutions.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering: Decades of mixed ownership and conflicting business models led to lots of character-building learnings... and the rebirth of Sterling The power of a rebrand and sense of togetherness to gain commercial traction Kevin’s five-point

en

52:32

AI as a force for good in drug development

Molecule to Market: Inside the outsourcing space ·

2024/07/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vijay Vaswani, Co-Founder & CEO at Omniscope.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vijay, covering: How travel expands the mind and enables you to amplify your network The founding story of Omniscope and its mission of using tech to help unlock the immune system AI can read the immune system in HD, helping with clinical

en

52:32

Harnessing tech to improve the economics of making...

Molecule to Market: Inside the outsourcing space ·

2024/07/05

In this episode of Molecule to Market, you’ll go inside the global drug development and GMP Manufacturing space with David Staunton, Head of Life Sciences Transformation at Cognizant.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: Why being a supplier is harder if you have not been on the client side An industry driven by change and the importance of digital strategy to drive business outcomes Why pharma companies need to be both

en

34:54

Tasty Topics: Addressing the potential impact of the...

Molecule to Market: Inside the outsourcing space ·

2024/06/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Tom Willson, Vice President of Contract Manufacturing at Pfizer CentreOne Hanna Lesch, Chief Technology Officer at Extothera Stephen Grant, entrepreneurial advisor and angel investor Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, Hanna, and Stephen, covering: Unraveling the potential seismic shift in the pharmaceutical outsourcing

en

44:56

Becoming...a world class scientific leader

Molecule to Market: Inside the outsourcing space ·

2024/06/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mihaela Simianu, Vice President of R&D and Operations at Singota Solutions.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mihaela, covering: How having physician parents in Romania motivated Mihaela into a career in the biopharmaceutical space What 17 years at Eli Lilly taught her about drug development and

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter